We are live on ! Find out more
KA

Kintegral Advisory Portfolio holdings

AUM $1.06B
1-Year Est. Return 24.93%
This Fund
S&P 500
This Quarter Est. Return
-4.78%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$126M
Cap. Flow
-$49.2M
Cap. Flow %
-4.66%
Top 10 Hldgs %
35.5%
Holding
234
New
Increased
1
Reduced
232
Closed
1

Top Buys

1
WAT icon
Waters Corp
WAT
+$167K

Sector Composition

1 Technology 34.77%
2 Financials 17.82%
3 Healthcare 14.43%
4 Communication Services 10.99%
5 Consumer Discretionary 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
76
Accenture
ACN
$88.5B
$3.78M 0.36%
19,075
-846
-4% -$197K
GIS icon
77
General Mills
GIS
$20.7B
$3.74M 0.35%
100,381
-4,451
-4% -$193K
WELL icon
78
Welltower
WELL
$170B
$3.65M 0.35%
18,451
-818
-4% -$162K
PGR icon
79
Progressive
PGR
$120B
$3.55M 0.34%
17,922
-795
-4% -$164K
MET icon
80
MetLife
MET
$60.3B
$3.54M 0.34%
50,099
-2,222
-4% -$166K
JCI icon
81
Johnson Controls International
JCI
$86.2B
$3.47M 0.33%
26,403
-1,171
-4% -$151K
CDNS icon
82
Cadence Design Systems
CDNS
$101B
$3.43M 0.33%
12,351
-548
-4% -$163K
PNR icon
83
Pentair
PNR
$10.6B
$3.41M 0.32%
39,189
-1,738
-4% -$170K
NOW icon
84
ServiceNow
NOW
$107B
$3.41M 0.32%
32,609
-1,446
-4% -$170K
FERG icon
85
Ferguson
FERG
$45.4B
$3.36M 0.32%
14,367
-637
-4% -$155K
ADBE icon
86
Adobe
ADBE
$93.5B
$3.32M 0.31%
13,654
-605
-4% -$168K
BIIB icon
87
Biogen
BIIB
$30.8B
$3.29M 0.31%
17,946
-796
-4% -$147K
BSX icon
88
Boston Scientific
BSX
$66.3B
$3.25M 0.31%
51,777
-2,296
-4% -$184K
TRV icon
89
Travelers Companies
TRV
$71.8B
$3.1M 0.29%
10,613
-471
-4% -$138K
NKE icon
90
Nike
NKE
$66.1B
$3.05M 0.29%
57,372
-2,544
-4% -$154K
ADSK icon
91
Autodesk
ADSK
$45.8B
$3.05M 0.29%
12,733
-565
-4% -$142K
UNP icon
92
Union Pacific
UNP
$178B
$3.05M 0.29%
12,552
-557
-4% -$136K
ZTS icon
93
Zoetis
ZTS
$32.2B
$3M 0.28%
25,355
-1,124
-4% -$139K
GWW icon
94
W.W. Grainger
GWW
$66.2B
$2.95M 0.28%
2,701
-120
-4% -$131K
HCA icon
95
HCA Healthcare
HCA
$85.6B
$2.94M 0.28%
6,206
-275
-4% -$138K
PRU icon
96
Prudential Financial
PRU
$41.1B
$2.93M 0.28%
30,036
-1,332
-4% -$138K
DE icon
97
Deere & Co
DE
$162B
$2.9M 0.27%
5,132
-228
-4% -$129K
IDXX icon
98
Idexx Laboratories
IDXX
$45.4B
$2.86M 0.27%
5,087
-226
-4% -$145K
VRTX icon
99
Vertex Pharmaceuticals
VRTX
$123B
$2.86M 0.27%
6,397
-284
-4% -$132K
TROW icon
100
T. Rowe Price
TROW
$25.5B
$2.83M 0.27%
31,356
-1,390
-4% -$135K

Similar funds

Kintegral Advisory's Q1 2026 Portfolio in Review

As of Q1 2026, Kintegral Advisory held 234 positions worth $1.06B, down 11% from $1.18B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kintegral Advisory withdrew a net $49.2M in Q1 2026, closing 1 position and reducing 232 holdings. Its most notable exit was Moderna, an estimated $85.3K position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Kintegral Advisory added an estimated $167K to Waters Corp.

  • Kintegral Advisory added most to Waters Corp in Q1 2026, an estimated $167K increase.
  • Kintegral Advisory's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.67M.
  • Kintegral Advisory fully exited Moderna in Q1 2026, selling an estimated $85.3K.
  • Kintegral Advisory's ten largest holdings make up 36% of its $1.06B portfolio in Q1 2026.
  • Kintegral Advisory opened 0 new positions and closed 1 in Q1 2026.
  • Kintegral Advisory's portfolio value fell 11% quarter-over-quarter to $1.06B.

Based on Kintegral Advisory's 13F filing for Q1 2026, filed 14 May 2026.